Your browser doesn't support javascript.
loading
Levels of hormones regulating appetite and energy homeostasis in response to a 1.5-Year combined lifestyle intervention for obesity.
Kuckuck, Susanne; van der Valk, Eline S; Scheurink, Anton J W; Lengton, Robin; Mohseni, Mostafa; Visser, Jenny A; Iyer, Anand M; van den Berg, Sjoerd A A; van Rossum, Elisabeth F C.
Afiliación
  • Kuckuck S; Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • van der Valk ES; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Scheurink AJW; Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Lengton R; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Mohseni M; Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, Netherlands.
  • Visser JA; Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Iyer AM; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • van den Berg SAA; Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • van Rossum EFC; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Front Physiol ; 14: 1010858, 2023.
Article en En | MEDLINE | ID: mdl-36891140
ABSTRACT

Background:

Weight loss can induce changes in appetite-regulating hormone levels, possibly linked to increases in appetite and weight regain. However, hormonal changes vary across interventions. Here, we studied levels of appetite-regulating hormones during a combined lifestyle intervention (CLI healthy diet, exercise and cognitive behavioral therapy).

Methods:

We measured levels of long-term adiposity-related hormones (leptin, insulin, high-molecular-weight (HMW) adiponectin) and short-term appetite hormones (PYY, cholecystokinin, gastric-inhibitory polypeptide, pancreatic polypeptide, FGF21, AgRP) in overnight-fasted serum of 39 patients with obesity. Hormone levels were compared between T0 (baseline), T1 (after 10 weeks) and T2 (end of treatment, 1.5 years). T0-T1 hormone changes were correlated with T1-T2 anthropometric changes.

Results:

Initial weight loss at T1 was maintained at T2 (-5.0%, p < 0.001), and accompanied by decreased leptin and insulin levels at T1 and T2 (all p < 0.05) compared to T0. Most short-term signals were not affected. Only PP levels were decreased at T2 compared to T0 (p < 0.05). Most changes in hormone levels during initial weight loss did not predict subsequent changes in anthropometrics, except for T0-T1 decreases in FGF21 levels and T0-T1 increases in HMW adiponectin levels tended to be associated with larger T1-T2 increases in BMI (p < 0.05 and p = 0.05, respectively).

Conclusion:

CLI-induced weight loss was associated with changes in levels of long-term adiposity-related hormones towards healthy levels, but not with orexigenic changes in most short-term appetite signals. Our data indicates that the clinical impact of alterations in appetite-regulating hormones during modest weight loss remains questionable. Future studies should investigate potential associations of weight-loss-induced changes in FGF21 and adiponectin levels with weight regain.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Physiol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Physiol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos